vs

Side-by-side financial comparison of BranchOut Food Inc. (BOF) and Opus Genetics, Inc. (IRD). Click either name above to swap in a different company.

BranchOut Food Inc. is the larger business by last-quarter revenue ($4.0M vs $3.9M, roughly 1.0× Opus Genetics, Inc.). On growth, BranchOut Food Inc. posted the faster year-over-year revenue change (181.9% vs -10.2%). Over the past eight quarters, BranchOut Food Inc.'s revenue compounded faster (65.4% CAGR vs 50.3%).

Food Lion is an American regional supermarket chain headquartered in Salisbury, North Carolina, that operates over 1,000 supermarkets in 10 states: Delaware, Georgia, Kentucky, Maryland, North Carolina, South Carolina, Pennsylvania, Tennessee, Virginia, and West Virginia. The chain employs over 82,000 people. It was founded in 1957 as Food Town, a single grocery store in Salisbury. It later expanded to many locations across North Carolina. It was independently operated until it was acquired b...

Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.

BOF vs IRD — Head-to-Head

Bigger by revenue
BOF
BOF
1.0× larger
BOF
$4.0M
$3.9M
IRD
Growing faster (revenue YoY)
BOF
BOF
+192.0% gap
BOF
181.9%
-10.2%
IRD
Faster 2-yr revenue CAGR
BOF
BOF
Annualised
BOF
65.4%
50.3%
IRD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BOF
BOF
IRD
IRD
Revenue
$4.0M
$3.9M
Net Profit
$-2.0M
Gross Margin
7.6%
Operating Margin
-47.6%
Net Margin
-50.6%
Revenue YoY
181.9%
-10.2%
Net Profit YoY
-36.5%
53.0%
EPS (diluted)
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BOF
BOF
IRD
IRD
Q4 25
$4.0M
$3.9M
Q3 25
$3.2M
$3.1M
Q2 25
$3.3M
$2.9M
Q1 25
$3.2M
$4.4M
Q4 24
$1.4M
$4.3M
Q3 24
$2.2M
$3.9M
Q2 24
$1.4M
$1.1M
Q1 24
$1.5M
$1.7M
Net Profit
BOF
BOF
IRD
IRD
Q4 25
$-2.0M
Q3 25
$-1.6M
$-17.5M
Q2 25
$-1.6M
$-7.4M
Q1 25
$-918.4K
$-8.2M
Q4 24
$-1.5M
Q3 24
$-1.3M
$-7.5M
Q2 24
$-942.6K
$-7.8M
Q1 24
$-1.1M
$-7.1M
Gross Margin
BOF
BOF
IRD
IRD
Q4 25
7.6%
Q3 25
17.7%
Q2 25
18.4%
Q1 25
17.3%
Q4 24
0.9%
Q3 24
15.4%
Q2 24
10.9%
Q1 24
19.3%
Operating Margin
BOF
BOF
IRD
IRD
Q4 25
-47.6%
Q3 25
-44.3%
-269.9%
Q2 25
-40.8%
-309.0%
Q1 25
-21.4%
-227.2%
Q4 24
-80.7%
Q3 24
-41.4%
-207.1%
Q2 24
-60.6%
-748.9%
Q1 24
-69.9%
-450.5%
Net Margin
BOF
BOF
IRD
IRD
Q4 25
-50.6%
Q3 25
-48.8%
-566.9%
Q2 25
-48.6%
-257.5%
Q1 25
-28.8%
-187.5%
Q4 24
-104.5%
Q3 24
-58.3%
-194.6%
Q2 24
-69.2%
-698.3%
Q1 24
-71.6%
-415.3%
EPS (diluted)
BOF
BOF
IRD
IRD
Q4 25
$-0.15
Q3 25
$-0.14
$-0.25
Q2 25
$-0.17
$-0.12
Q1 25
$-0.11
$-0.24
Q4 24
$-0.16
Q3 24
$-0.19
$-0.29
Q2 24
$-0.22
$-0.30
Q1 24
$-0.26
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BOF
BOF
IRD
IRD
Cash + ST InvestmentsLiquidity on hand
$45.1M
Total DebtLower is stronger
$4.9M
Stockholders' EquityBook value
$5.6M
$15.3M
Total Assets
$14.5M
$50.2M
Debt / EquityLower = less leverage
0.89×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BOF
BOF
IRD
IRD
Q4 25
$45.1M
Q3 25
$30.8M
Q2 25
$32.4M
Q1 25
$41.8M
Q4 24
$30.3M
Q3 24
$36.6M
Q2 24
$41.4M
Q1 24
$47.2M
Total Debt
BOF
BOF
IRD
IRD
Q4 25
$4.9M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BOF
BOF
IRD
IRD
Q4 25
$5.6M
$15.3M
Q3 25
$5.1M
$6.0M
Q2 25
$3.5M
$17.5M
Q1 25
$3.9M
$5.1M
Q4 24
$2.3M
$6.7M
Q3 24
$1.5M
$34.3M
Q2 24
$2.0M
$40.6M
Q1 24
$1.7M
$46.1M
Total Assets
BOF
BOF
IRD
IRD
Q4 25
$14.5M
$50.2M
Q3 25
$14.7M
$36.1M
Q2 25
$13.2M
$38.7M
Q1 25
$14.1M
$48.2M
Q4 24
$12.9M
$36.9M
Q3 24
$9.6M
$40.4M
Q2 24
$6.7M
$44.8M
Q1 24
$2.7M
$51.8M
Debt / Equity
BOF
BOF
IRD
IRD
Q4 25
0.89×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BOF
BOF
IRD
IRD
Operating Cash FlowLast quarter
$-1.9M
$-35.3M
Free Cash FlowOCF − Capex
$-2.1M
FCF MarginFCF / Revenue
-52.6%
Capex IntensityCapex / Revenue
4.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BOF
BOF
IRD
IRD
Q4 25
$-1.9M
$-35.3M
Q3 25
$-1.1M
$-6.2M
Q2 25
$-2.0M
$-10.3M
Q1 25
$-1.9M
$-9.0M
Q4 24
$-1.6M
$-25.6M
Q3 24
$-1.9M
$-5.1M
Q2 24
$-853.9K
$-7.3M
Q1 24
$-503.6K
$-5.7M
Free Cash Flow
BOF
BOF
IRD
IRD
Q4 25
$-2.1M
Q3 25
$-1.2M
Q2 25
$-2.1M
Q1 25
$-2.3M
Q4 24
$-2.3M
Q3 24
$-3.4M
Q2 24
$-1.4M
Q1 24
$-553.6K
FCF Margin
BOF
BOF
IRD
IRD
Q4 25
-52.6%
Q3 25
-37.4%
Q2 25
-64.5%
Q1 25
-72.2%
Q4 24
-163.6%
Q3 24
-157.9%
Q2 24
-101.3%
Q1 24
-37.7%
Capex Intensity
BOF
BOF
IRD
IRD
Q4 25
4.3%
Q3 25
2.6%
Q2 25
3.4%
Q1 25
11.8%
Q4 24
51.1%
Q3 24
70.8%
Q2 24
38.6%
Q1 24
3.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons